Year: 2023

Update on Asthma Management: the 2022 GINA Report

Theresa Capriotti; Natalie Dawn; Tabitha Ciocco Asthma is a common airway disease in the United States with 8.4% of adults or 21 million persons affected.1 Of this population, approximately 60% have inadequately controlled disease.2 Asthma is one of the leading chronic illnesses of childhood and disproportionately affects Black people and those living below the poverty level.1 Asthma exacerbations cause […]

Sustained Benefits With Mepolizumab in Severe Eosinophilic Asthma

A fifth of patients no longer needed oral steroids 2 years after starting biologic by Salynn Boyles SAN ANTONIO — Treatment with the interleukin-5 (IL-5) antagonist mepolizumab (Nucala) increased freedom from oral corticosteroids after 2 years in patients with severe eosinophilic asthma, according to a post-hoc analysis of the real-world prospective REALITI-A trial. The proportion of […]

Air Pollution Linked to Development and Progression of Chronic Lung Disease

Sheila Jacobs  Among pollutants studied, particulate matter of 2.5 μM had the greatest association with the progression trajectory of chronic lung multimorbidity. Air pollution may adversely affect lung health by promoting the progression of lungs from a state of health to subsequently having chronic lung disease, chronic lung multimorbidity, and, ultimately, a fatal lung condition, […]

Patients With Asthma, Obesity Have Increased Risk for Near-Fatal Asthma Events

Ron Goldberg  Patients with asthma and obesity had longer hospitalizations, higher care costs, and a more near-fatal asthma events than those without obesity. An increased risk for near-fatal asthma events may exist among patients with asthma and comorbid obesity, according to review findings presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 […]

Benchmarking omics-based prediction of asthma development in children

Research – Open Access Xu-Wen Wang, Tong Wang, Darius P. Schaub, Can Chen, Zheng Sun, Shanlin Ke, Julian Hecker, Anna Maaser-Hecker, Oana A. Zeleznik, Roman Zeleznik, Augusto A. Litonjua, Dawn L. DeMeo, Jessica Lasky-Su, Edwin K. Silverman, Yang-Yu Liu & Scott T. Weiss  Respiratory Research volume 24, Article number: 63 (2023) Abstract Background Asthma is a heterogeneous disease with high morbidity. Advancement in high-throughput multi-omics approaches has enabled the collection of molecular assessments at different layers, […]

Recommendations from a Canadian Delphi consensus study on best practice for optimal referral and appropriate management of severe asthma

Research – Open Access K. Godbout, M. Bhutani, L. Connors, C. K. N. Chan, C. Connors, D. Dorscheid, G. Dyck, V. Foran, A. G. Kaplan, J. Reynolds & S. Waserman  Allergy, Asthma & Clinical Immunology volume 19, Article number: 12 (2023)  Abstract Background In Canada, severe asthma affects an estimated 5–10% of people with asthma and is associated with frequent exacerbations, poor symptom control and significant morbidity from the disease itself, […]

Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong

Wang Chun Kwok, Terence Chi Chun Tam, David Chi Leung Lam, Jackson Ka Chun Leung, King Pui Florence Chan, Shung Kay Samuel Chan, Ka Yan Chiang, Mary Sau Man Ip & James Chung Man Ho  Respiratory Research volume 24, Article number: 53 (2023)  Abstract Background While there are postulations that asthma is potentially associated with severe coronavirus disease 2019 (COVID-19), there has been conflicting results from studies on the […]

Anti-Asthmatic Drug Prescriptions Decreased During COVID-19 Pandemic

Colby Stong  During the pandemic, the monthly volume of anti-asthmatic prescriptions was about 18.1% lower than predicted based on previous prescription rates. Prescriptions for anti-asthmatic medications had an overall significant decrease during the first year of the COVID-19 pandemic, especially for bronchodilators, according to study findings published in Clinical Therapeutics. Researchers assessed the impact of the […]

New for Journal of Asthma online now on Taylor & Francis Online: 

Research Article  Prevalence and risk factors for self-reported asthma among sámi in Sweden: a cross-sectional study | Emil Xabier San Sebastián, Jon Petter Stoor PhD & Miguel San Sebastian PhDPages: 1-7 | DOI: 10.1080/02770903.2023.2169933 Interval change in fractional exhaled nitric oxide (FENO) reflects short-term change in adherence following electronic inhaler remindersTunn Ren Tay MBBS, FRCP, Anthony Yii MB […]